Kv1.3 ion channel

Class

Ion channel blocker (effector-memory T-cell-targeting peptide)

Kv1.3 is a voltage-gated potassium channel that helps set the electrical properties of immune cells, particularly a subset of T lymphocytes called effector memory T cells. When these cells are activated, calcium enters through specialized channels to drive signaling that leads to proliferation and cytokine release; potassium efflux through Kv1.3 maintains the electrical gradient that keeps this calcium influx going. Blocking Kv1.3 depolarizes the cell membrane and interrupts this calcium signal, dampening activation of effector memory T cells more selectively than of naive or central memory T cells, which rely on a different potassium channel for the same purpose. This selectivity is the biological rationale for developing Kv1.3 blockers: effector memory T cells are disproportionately implicated in chronic autoimmune and inflammatory conditions such as psoriasis, multiple sclerosis, and rheumatoid arthritis, so suppressing this subset offers a way to blunt pathological immune activity while leaving broader immune surveillance more intact than conventional, non-selective immunosuppression would. Peptide-based blockers, often derived from natural scorpion or sea anemone toxins, are commonly used to achieve high potency and selectivity for this channel given its structural similarity to other Kv1 family members expressed elsewhere in the body, including in neurons and cardiac tissue.